Clinical Trials Update: Sept. 25, 2006
Migraine and Cluster Headaches Contraception Erectile Dysfunction
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Migraine and Cluster Headaches
This study will evaluate an FDA-approved medicine to prevent migraine headaches. Volunteers 18-65 may be eligible who have at least a one-year history of migraines, have migraines 10-14 days per month, and are willing to substitute current migraine medicine with the study drug.
The research site is in Cincinnati, Ohio.
Women are needed for this clinical research study of an investigational oral birth control medication. Women 18-45 who are sexually active and have regular menstrual cycles may be eligible. Compensation up to $150 is available for time and travel.
The research site is in Moorestown, NJ.
This study will evaluate an investigational medication to treat abnormal cholesterol and erectile dysfunction. Men 18-64 in a stable heterosexual relationship who have had ED for at least six months and who are on a stable dose of a cholesterol-lowering drug may qualify.
The research site is in Lawrenceville, NJ.
Copyright 2006 Thomson CenterWatch. All rights reserved.